Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Pomalidomide, Pembrolizumab, Medicine, PARP1, DNA damage, and Poly ADP ribose polymerase.
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer
Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)